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ABSTRACT 
Objective: The aim of this research was to investigate and evaluate the drug release characteristics (models and drug release profiles) using natural 
polymers (pectin, carrageenan and glucomannan) in water soluble drug of sustained release tablet. 
Methods: Captopril was used as drug model. Tablet were prepared using wet granulation method. Pectin, carrageenan and glucomannan were used 
as matrix with various concentration. Physical properties inspections were conducted on granules and tablets. Dissolution test using apparatus II 
USP model with 50 rpm of speed rotation, 900 ml of HCl 0.1N as medium. The results were analyzed statistically by MANOVA, dependent model and 
independent model. 
Results: The results showed that enhancement of matrix concentrations decreased the fluidity and compact-ability. Drug release of soluble drug 
using pectin as matrix had not significant different than without matrix.  
Conclusion: Tablet using glucomannan and carrageenan as matrix controlled the drug release with initial burst release effect. Weibull models was 
the best fitting model of release kinetics with the highest coefficient of determination and similarity between predicted and observed data  and the 
release mechanisms were controlled by anomalous transport. 
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INTRODUCTION 
Hydrophilic natural polymer matrix systems are widely used in oral 
controlled drug delivery because of their flexibility to obtain a 
desirable drug release profile, cost-effectiveness and broad 
regulatory acceptance. The ability of the hydrophilic polymer 
matrices to release an entrapped drug in aqueous medium and to 
regulate the release of such drug by control of swelling and cross-
linking makes them particularly suitable for controlled release 
applications [1]. Recently many controlled release formulations 
based on hydrophilic and natural polymer matrices have been 
developed [2]. 
Carrageenan is a family of sulfated polysaccharides extracted from 
red marine algae and that are widely utilized. These polysaccharides 
are linier polymers consisting of chains of (13)-linked β-D-
galactose and (14)-linked α-D-galactose units which are variously 
substituted and modified to the 3,6-anhydro derivate, depending on 
the source and extraction condition [3]. Pharmaceutical applications, 
carrageenan was used as excipient in emulsions, gels, creams, 
lotions, eye drops, suppositories, tablets and capsules [4]. 
Pectin are hydrophilic polysaccharides derived from plant cell walls. 
They content linier of (14) linked α-D-galacturonic acid residue. 
This uronic acid have carboxyl group, some of which are naturally 
presented as methyl esters [5]. Pectin gelation characteristics 
depend of methoxy group. Gelation of high methoxy pectin usually 
occurs at pH <3.5 and low-methoxy of pectin is gelled with calcium 
ions [6]. Glucomannan is polysaccharide with high molecular weight 
consist of D-mannose and D-glucose, can produce firm gel upon 
contact with water. The firm gel of konjac glucomannan as a 
potential to control the drug release [7]. 
Hence, the aim of this research was to investigate and evaluate the 
drug release characteristics of a captopril sustained release tablet 
formulation as model drug with high water soluble drug using 
natural polymer matrices such as carrageenan, pectin and 
glucomannan. 
MATERIALS AND METHODS 
Materials 
Captopril was purchased from Afine Chemicals Limited (Hangzhou, 
China), pectin (Cargill, Germany) and magnesium stearate (Peter 
Greven, Germany) were purchased from Bratachem Chemical 
(Surakarta, Indonesia), carragenan was purchased from Bogor 
Agricultural Institute (Bogor, Indonesia), glucomannan was 
extracted from Amorphophallus muelleri (Indonesia), all other 
chemicals were of pharmaceutical grade. Hydrochloric acid was 
purcashed from Merck (Darmstadt, Germany) was of analytical 
grade and demineralized water. 
Methods 
Tablet formulation 
Captopril a water-soluble drug was used as drug model. A 20% (50 mg) 
captopril was used of each tablet, using 1% magnesium stearate as 
lubricant and lactose as filler to adjust the weight of tablets (250 mg). 
Amount of matrices were added according to Table 1. 
 
Table 1: Composition of formula 
Matrices Formulas 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
Pectin - 50 100 150 - - - - - - 
Carrageenan - - - - 50 100 150 - - - 
Glucomannan - - - - - - - 50 100 150 
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Preparation of captopril tablet 
Tablets were formulated according to Table 1. Wet granulation 
method was employed for formulation. All of the components in 
formula except lubricant (1% magnesium stearate) were mixed in 
the mixer for 16 minutes 25 rpm followed by addition demineralized 
water to the blend until elastic mass of wet granules was achieved. 
Mass of wet granules were passed through 16 mesh sieve. Wet 
granules were dried in oven at temperature 40oC for 6 hours. The 
dried granules were passed through 18 mesh sieve and" within were 
and mixed with magnesium stearate in mixer for 4 minutes 25 rpm. 
The granules were characterized by particle size distribution test with 
analytical sieving, moisture content, bulk density and tapped density. 
The mass of tablets were characterized by fluidity and compact-ability, 
the compact-ability was conducted with the deepness of upper punch 
of 5.3 mm and the lower punch of 8.15 mm. 
The tablet compression process used single punch tablet machine 
model TDP-1 Shanghai, China. The weight of tablets were arranged 
250 mg and the hardness were controlled 10-12 kg and were tested 
using Gouming YD-1 hardness tester. 
Drug release 
The drug releases were determined using Electrolab TDT-08L 
dissolution tester type apparatus II (paddle method), 900 ml of HCl 
0.1N as dissolution medium maintained at 37±0.5oC at 50 rpm for 6 
hours. Aliquots of 10 ml were withdrawn at 15, 30, 45, 60, 90, 120, 
180, 240, 300 and 360 minutes with replacement of 10 ml of the 
fresh media. All the samples were analyzed directly at 202.4 nm 
(λmax
Therefore six kinetic models were applied to analyze the drug 
release data to find the best fitting equation. These models are zero-
order release, first-order release, Hixson-Crowell, Weibull, Higuchi 
release and Korsmeyer-Peppas. The release mechanism based on 
the exponential diffusion value (n) of Korsmeyer-Peppas equation. 
The best fitting equation based on coefficient of determination (R
 of captopril) using an UV-Vis Hitachi U-2900 spectro 
photometer. 
Drug release kinetics 
Drug release kinetics is assumed to reflect different release 
mechanism of controlled release matrix system.  
2
Statistical analysis  
), 
AIC (Akaike’s Information Criterion) and RMSE (root mean square 
error).  
The drug release (dissolution efficiency 360 minutes (DE360), 
cumulative drug release at 60 minutes (Q60) and mean dissolution 
time (MDT)) were analyzed statistically by MANOVA level of 95% (p 
= 0.05), if significant different followed by t-LSD test. The drug 
releases were computed by free open source software KinetDS® 
RESULTS AND DISCUSSION 
[8]. 
Physical properties of mass tablet was shown in Table 2. Granules 
using pectin and carrageenan showed that enhancement of matrix 
concentrations increased the fluidity. Granules using glucomannan 
as matrix, enhancement of matrix concentration reduced fluidity, the 
fluidity was shown by flow time and angle of repose. Enhancement 
of matrix concentrations reduced the compact-ability. The fluidity 
was directly affected by moisture content, bulk density and tapped 
density. Decreasing the compact-ability were affected of elastic 
deformation of the matrices. Free flowing of granules not less than 
10 second for 100 gram granules [9]. The particle distribution size 
was shown by the amount of fines in each formula less than 10% 
and the particle size normally distributed. Good flow-ability will 
produce uniform dosage form with constant filling granules in the 
compression room. Compact-ability was shown by the tablet 
hardness after compaction, higher of compact-ability the mass of 
tablet will easily be compressed and formed compact mass with low 
pressure. 
 
Table 2: Physical properties of granules (mean ± SD) 














F1 0.629±0.01 0.731±0.01 0.50±0.00 5.08±0.38 1.28±0.16 24.90±0.81 
F2 0.624±0.01 0.714±0.00 2.33±0.29 5.24±0.50 3.71±0.28 23.10±1.22 
F3 0.655±0.01 0.744±0.01 3.16±0.29 4.26±0.48 2.73±0.30 23.02±1.45 
F4 0.560±0.01 0.653±0.01 3.33±0.29 4.96±0.34 1.58±0.13 25.61±0.47 
F5 0.482±0.00 0.537±0.01 3.63±0.32 6.24±0.13 1.38±0.34 27.56±0.35 
F6 0.476±0.00 0.548±0.00 4.47±0.06 6.60±0.23 1.21±0.41 28.44±0.92 
F7 0.533±0.00 0.600±0.01 5.30±0.26 5.76±0.17 0.96±0.04 27.97±0.86 
F8 0.514±0.01 0.615±0.01 1.60±0.61 5.50±0.28 4.40±0.90 25.72±0.44 
F9 0.500±0.00 0.566±0.01 1.87±0.81 6.27±0.22 2.22±0.43 27.03±0.75 
F10 0.500±0.00 0.590±0.00 2.97±0.95 6.91±0.19 1.47±0.17 29.50±1.15 
 
Table 3: Physical properties of captopril tablets (mean ± SD) 
Formulas Hardness (kg) Drug content (%)  DE360 MDT (minutes)  (%) Q60 (%) 
F1 4.52±0.28 96.29±2.85 90.64±3.42 16.99±1.48 89.77±6.37 
F2 12.17±0.79 102.83±4.22 84.00±2.18 54.59±4.15 75.26±3.60 
F3 11.12±1.06 99.91±5.37 86.08±1.44 43.32±8.86 82.50±2.97 
F4 10.14±0.61 97.28±4.09 87.53±2.96 43.27±7.89 83.79±6.00 
F5 10.74±0.42 111.71±1.68 55.68±2.34 123.95±3.61 34.59±0.34 
F6 10.48±0.79 110.18±2.04 57.60±2.00 117.30±3.00 34.31±0.35 
F7 10.86±0.98 107.68±2.55 60.03±0.81 110.41±9.39 43.79±2.72 
F8 12.08±0.64 105.27±3.02 63.14±3.79 84.85±4.55 37.09±0.83 
F9 10.54±0.67 101.99±3.72 73.40±1.81 63.53±12.01 55.21±8.63 
F10 9.28±0.50 99.57±2.68 79.22±3.94 44.43±3.06 74.92±3.69 
 
Uniformity of dosage form was determined by the drug content of 
captopril tablets. Uniformity of dosage form as required in 
Indonesian Pharmacopeia IV, otherwise the drug content not less 
than 85% and not more than 115% with the relative standard 
deviation not more than 6% [10].  
The controlled hardness of tablet was expected the hardness not 
affected the drug release from dosage form. 
Fig. 1 showed that the drug release from natural polymers based 
sustained release captopril tablets. Drug release using pectin, 
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carrageenan and glucomannan as matrices, enhancement of matrix 
concentrations increased drug release was shown by DE360, 
decreasing MDT and increasing Q60
 
Fig. 1: Drug release of captopril natural-polymers based 




Different concentrations (p<0.05) and different matrices (p<0.05) 
provided the different of DE360, MDT and Q60. Formula using pectin 
as matrix not significant different than the tablet without matrix 
(p>0.05) in DE360, MDT and Q60
Desirable drug release profiles indicating the drug release lower 
than drug release tablet without matrix with lower DE
. Captopril as water soluble drug, low 
compact-ability of pectin affected the interparticle bonding, thus the 
particle disintegration rapidly upon contact with medium and 
matrix act as gel forming layer with water-uptake pass through the 
porous of tablet, and the amount of absorbed water increased with 
enhancement of matrix concentrations. Enhancement of matrix 
concentration increased the swelling ability then followed by 
erosion and the drug released from matrix. Lactose acted as 
channeling agent and form porous matrix thus increasing the drug 
release rate [11]. Previous work showed that glucomannan 
controlled the slightly soluble drug (metronidazole) slowly for 12 
hours [12]. 
360 and Q60
Table 4: Models and kinetics release captopril natural polymer based sustained release tablet 
, 
and longer mean dissolution time (MDT) than tablet without matrix. 
Tablet using carrageenan and glucomannan showed the slower 
release than tablet without matrix. 
Model Statistics F5 F6 F7 F8 F9 F10 
Zero-order R 0.943 2 0.929 0.907 0.796 0.746 0.677 
RMSE 5.50 6.65 6.28 11.87 11.06 6.64 
AIC 61.13 64.92 63.79 76.50 75.10 64.89 
First-order R 0.803 2 0.780 0.756 0.665 0.612 0.578 
RMSE 10.83 13.84 9.63 19.47 14.31 7.03 
AIC 74.67 79.59 72.33 86.40 80.24 66.03 
Higuchi R 0.978 2 0.945 0.929 0.877 0.653 0.534 
RMSE 3.39 5.79 5.50 9.23 12.95 29.41 
AIC 51.47 62.16 61.12 71.15 78.25 94.65 
Hixson-Crowell R 0.859 2 0.840 0.814 0.714 0.661 0.611 
RMSE 8.30 10.36 8.11 15.64 12.81 6.87 
AIC 69.36 73.79 68.89 82.02 78.04 65.57 
Weibull R 0.986 2 0.992 0.987 0.961 0.972 0.931 
β 0.786 0.872 0.641 0.868 0.681 0.343 
RMSE 2.61 2.01 2.32 5.36 3.23 3.20 
AIC 46.19 40.96 43.90 60.62 50.47 50.29 
Korsmeyer-Peppas R 0.985 2 0.983 0.976 0.934 0.913 0.847 
n 0.563 0.628 0.451 0.649 0.406 0.393 
RMSE 2.66 3.45 2.76 8.14 6.38 4.06 
AIC 46.61 51.77 47.33 68.95 64.07 55.03 
k = drug release constant rate, β = shape parameter of Weibull equation. 
 
Some kinetic release models were applied to describe the drug 
release from tablet were zero-order release, first-order release, 
Higuchi model’s, Weibull model’s, Hixson-Crowell equation and 
Korsmeyer-Peppas equation. Mechanism of drug release based on 
the exponential diffusion coefficient of Korsmeyer-Peppas equation, 
fick diffusion (n = 0.45), anomalous transport (0.45<n<0.89), case II 
transport (n = 0.89) and super case II transport (n>0.89) [13]. 
 Mechanism of captopril release from tablet was controlled by 
anomalous transport showed by exponential diffusion value within 
0.45 to 0.89. F7 and F9 the drug release were controlled by fick 
diffusion with initial burst release [14]. The kinetic release to 
describe the drug release based on the goodness of fit there are the 
highest of determination coefficient, the lowest of RMSE and the 
lowest of AIC, the selected model have similarity between observed 
and predicted model [15].  
Weibull model was the best fitting to describe kinetic releases. The 
model has function between log-log from plot time with –ln fraction 
of cumulative drug left. Based on β of Weibull model’s (β<1) 
indicating that the initial burst release with higher slope in the initial 
time followed drug release exponentially [16]. Initial burst release 
effect indicating the high soluble of drug with the matrix 
uncontrolled drug release in the initial time [17]. 
CONCLUSION 
Natural polymer-based matrix tablets of water soluble drug 
(captopril) were prepared using pectin, carrageenan and 
glucomannan. Formulas with glucomannan and carrageenan as 
matrix controlled the drug release with initial burst release effect. 
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